Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Brain Tumor Radiotherapy Using an Auger Emitter
Giacomo Pirovano, Stephen A. Jannetti, Lukas M. Carter, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 12, pp. 2871-2881
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations
Dmitry Filosofov, Elena Kurakina, Valery Radchenko
Nuclear Medicine and Biology (2020) Vol. 94-95, pp. 1-19
Closed Access | Times Cited: 317
Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
Stephen A. Jannetti, Brian M. Zeglis, Michael R. Zalutsky, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 76
Radionuclides for Targeted Therapy: Physical Properties
Caroline Stokke, Monika Kvassheim, Johan Blakkisrud
Molecules (2022) Vol. 27, Iss. 17, pp. 5429-5429
Open Access | Times Cited: 43
Next generation radiotheranostics promoting precision medicine
Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, et al.
Annals of Oncology (2023) Vol. 34, Iss. 6, pp. 507-519
Open Access | Times Cited: 37
Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy
Julie Bolcaen, Mohamed A. Gizawy, Samantha Y.A. Terry, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1344-1351
Open Access | Times Cited: 34
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 33
Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment
Zahra Abousalman‐Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 15
Advances in Radioligand Theranostics in Oncology
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11
PARP Inhibitors in Cancer Diagnosis and Therapy
Chung Ying Chan, Kel Vin Tan, Bart Cornelissen
Clinical Cancer Research (2020) Vol. 27, Iss. 6, pp. 1585-1594
Open Access | Times Cited: 61
Biomaterial-mediated internal radioisotope therapy
Pei Pei, Teng Liu, Wenhao Shen, et al.
Materials Horizons (2020) Vol. 8, Iss. 5, pp. 1348-1366
Closed Access | Times Cited: 58
Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation
Juan Sun, Zhenyuan Huangfu, Jiangtao Yang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114538-114538
Closed Access | Times Cited: 33
Synthesis of Radioiodinated Compounds. Classical Approaches and Achievements of Recent Years
Stanislav A. Petrov, Mekhman S. Yusubov, Елена К. Белоглазкина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13789-13789
Open Access | Times Cited: 33
[123I]CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
Chung Ying Chan, Zijun Chen, Florian Guibbal, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 12, pp. 1965-1971
Open Access | Times Cited: 17
Immunological effects of radiopharmaceutical therapy
Amanda G. Shea, Malick Bio Idrissou, Ana Isabel Torres, et al.
Frontiers in Nuclear Medicine (2024) Vol. 4
Open Access | Times Cited: 6
Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach
Samuele Lodovichi, Tiziana Cervelli, Achille Pellicioli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6684-6684
Open Access | Times Cited: 43
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
Julie Bolcaen, Janke Kleynhans, Shankari Nair, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 7911-7947
Open Access | Times Cited: 39
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer
Sreeja Sreekumar, Dong Zhou, Cedric Mpoy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3083-3083
Open Access | Times Cited: 16
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair
Yousef Khazaei Monfared, Pedram Heidari, Samuel J. Klempner, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2761-2761
Open Access | Times Cited: 14
Targeted Radionuclide Therapy in Glioblastoma
Xiaobin Zhao, Vivianne Jakobsson, Yucen Tao, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 31, pp. 40391-40410
Closed Access | Times Cited: 5
Use of radioiodine in nuclear medicine—A brief overview
Trevor J. Ferris, Laurence Carroll, Sarah Jenner, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2020) Vol. 64, Iss. 3, pp. 92-108
Closed Access | Times Cited: 37
Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
Ramya Ambur Sankaranarayanan, Susanne Kossatz, Wolfgang Weber, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2130-2130
Open Access | Times Cited: 34
Auger: The future of precision medicine
Giacomo Pirovano, Thomas C. Wilson, Thomas Reiner
Nuclear Medicine and Biology (2021) Vol. 96-97, pp. 50-53
Open Access | Times Cited: 29
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas Vogg, et al.
Cancers (2022) Vol. 14, Iss. 1, pp. 230-230
Open Access | Times Cited: 20
The Auger spectrum of benzene
Nayanthara Karippara Jayadev, Anthuan Ferino-Pérez, Florian Matz, et al.
The Journal of Chemical Physics (2023) Vol. 158, Iss. 6
Open Access | Times Cited: 13
Clinical Evidence of Combining Radiopharmaceutical Therapy With Immune Checkpoint Inhibitors
Malick Bio Idrissou, Anusha Muralidhar, Reinier Hernandez, et al.
Applied Radiation Oncology (2025) Vol. 14, Iss. 1, pp. 6-16
Closed Access
Page 1 - Next Page

Scroll to top